Humana raises 2026 adjusted EPS outlook to at least $9.50 and expects Gentiva divestment proceeds
FROM THE WIRE · FINANCE.YAHOO.COM
This article first appeared on GuruFocus. Adjusted EPS Outlook (FY2026): Raised to at least $9.50, up from prior guidance of at least $9. Individual MA Pretax Margin: On track to double in 2026, excluding the Stars headwind. Cost Trends: In line to better than expectations for…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishThe raised earnings outlook is a positive factor for the stock in the health insurance sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01The 2026 adjusted EPS outlook was raised to at least $9.50 from at least $9.
- 02The Gentiva divestment is expected to bring total pretax proceeds of about $900 million.
- 03The member-weighted Star rating is 4.17, approaching Humana's highest ever.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets